Due to the current limited capacity to provide digital mammography-based screening to all women, and the lack of modern surgical oncology methods, mastectomy is still the predominant form of surgical treatment in many parts of the world. As such there is little incentive to detect breast cancer earlier and significant fear of treatment and outcomes continues to contribute to late presentations. Neoadjuvant chemotherapy, pre-operative breast MRI and surgical mapping techniques can combine forces to allow for more women to be treated with breast conservation, decrease fear of treatment and improve outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.hoc.2023.06.002 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!